The related transcriptional enhancer factor-1 Isoform, TEAD4216, can repress vascular endothelial growth factor expression in mammalian cells

Binoy Appukuttan, T McFarland, A Stempel, J Kassem, M Hartzell, Y Zhang, D Bond, K West, R Wilson, A Stout, Y Pan, H Ilias, K Robertson, M Klein, D Wilson, Justine Smith, J Stout

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    Increased cellular production of vascular endothelial growth factor (VEGF) is responsible for the development and progression of multiple cancers and other neovascular conditions, and therapies targeting post-translational VEGF products are used in the treatment of these diseases. Development of methods to control and modify the transcription of the VEGF gene is an alternative approach that may have therapeutic potential. We have previously shown that isoforms of the transcriptional enhancer factor 1-related (TEAD4) protein can enhance the production of VEGF. In this study we describe a new TEAD4 isoform, TEAD4216, which represses VEGF promoter activity. The TEAD4216 isoform inhibits human VEGF promoter activity and does not require the presence of the hypoxia responsive element (HRE), which is the sequence critical to hypoxia inducible factor (HIF)-mediated effects. The TEAD4216 protein is localized to the cytoplasm, whereas the enhancer isoforms are found within the nucleus. The TEAD4216 isoform can competitively repress the stimulatory activity of the TEAD4434 and TEAD4148 enhancers. Synthesis of the native VEGF165 protein and cellular proliferation is suppressed by the TEAD4216 isoform. Mutational analysis indicates that nuclear or cytoplasmic localization of any isoform determines whether it acts as an enhancer or repressor, respectively. The TEAD4216 isoform appears to inhibit VEGF production independently of the HRE required activity by HIF, suggesting that this alternatively spliced isoform of TEAD4 may provide a novel approach to treat VEGF-dependent diseases.

    Original languageEnglish
    Article numbere31260
    Pages (from-to)e31260
    Number of pages12
    JournalPLoS One
    Volume7
    Issue number6
    DOIs
    Publication statusPublished - 2012

    Fingerprint Dive into the research topics of 'The related transcriptional enhancer factor-1 Isoform, TEAD4216, can repress vascular endothelial growth factor expression in mammalian cells'. Together they form a unique fingerprint.

  • Cite this

    Appukuttan, B., McFarland, T., Stempel, A., Kassem, J., Hartzell, M., Zhang, Y., Bond, D., West, K., Wilson, R., Stout, A., Pan, Y., Ilias, H., Robertson, K., Klein, M., Wilson, D., Smith, J., & Stout, J. (2012). The related transcriptional enhancer factor-1 Isoform, TEAD4216, can repress vascular endothelial growth factor expression in mammalian cells. PLoS One, 7(6), e31260. [e31260]. https://doi.org/10.1371/journal.pone.0031260